Benchmark lowered the firm’s price target on LiveRamp (RAMP) to $38 from $53 and keeps a Buy rating on the shares. The firm’s forecast “conservatively” reflects FY27-29 revenue and adjusted EBITDA compound annual growth rates of 6.7% and 10.3%, respectively, the analyst tells investors in an earnings preview.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RAMP: